A new nitric oxide donor, NOC-18, exhibits a nociceptive effect in the rat formalin model

Journal of the Neurological Sciences

Volumn 141, Issue 1-2, 1996, Pages 1-5

  Shibuta, Satoshi ^a   Mashimo, Takashi ^a   Zhang, Ping ^a   Ohara, Akitoshi ^a   Yoshiya, Ikuto ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Formalin pain model; Methylene blue; Nitric oxide; NO releasing compound; NOC 18; Nociception

Indexed keywords

3,3 BIS(2 AMINOETHYL) 1 HYDROXY 2 OXOTRIAZENE; FORMALDEHYDE; GUANYLATE CYCLASE; METHYLENE BLUE; NITRIC OXIDE; NITRIC OXIDE DONOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR; CONTROLLED STUDY; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MALE; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0030587558     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0022-510X(96)00102-5     Document Type: Article

References (48)

1. Abram, S.E. and Yaksh, T.L. (1993) Morphine but inhalation anesthesia blocks post-injury facilitation: The role of preemptive suppression of afferent transmission. Anesthesiology, 78: 713-721.
2. Babbedge, R.C., Hart, S.L. and Moore, P.K. (1993) Anti-nociceptive activity of nitric oxide synthase inhibitors in the mouse: dissociation between the effects of L-NAME and L-NMMA. J. Pharm. Pharmacol., 45: 77-79.
3. Bohme, G.A., Bon, G., Stutzman, J.M., Doble, A. and Blanchard, J.C. (1991) Possible involvement of nitric oxide in long-term potentiation. Eur. J. Pharmacol., 199: 379-381.
4. Bredt, D.S. and Snyder, S.H. (1990) Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme. Proc. Natl. Acad. Sci. USA, 87: 682-685.
5. Bredt, D.S. and Snyder, S.H. (1992) Nitric oxide, a novel neural messenger. Neuron, 8: 3-11.
6. Bult, H., Boeckxstaens, G.E., Pelckmans, P.A., Jordaens, F.H., van Maerke, Y.M. and Herman, A.G. (1990) Nitric oxide as an inhibitory non-adrenergic non-cholinergic neurotransmitter. Nature, 345: 346-347.
7. Coderre, T.J. and Yashpal, K. (1994) Intracelluiar messengers contributing to persistent nociception and hyperalgesia induced by L-glutamate and substance P in the rat formalin pain model. Eur. J. Neurosci., 6: 1328-1334.
8. Dickenson, A.H. (1995) Spinal cord pharmacology of pain. Br. J. Anaesth., 75: 193-200.
9. Dubuisson, D. and Dennis, S.G. (1977) The formalin test: a quantitative study of the analgesic effect of morphine, meperidine, and brain stem stimulation in rats and cats. Pain 4: 161-174.
10. Frederickson, R.C., Burgis, V. and Edwards, J.D. (1977) Hyperalgesia induced by naloxone follows diurnal rhythm in responsivity to painful stimuli. Science, 198: 756-758.
11. Gally, J.A., Montague, P.R., Reeke, G.N. and Edeman, G.M. (1990) The NO hypothesis: Possible effects of a short-lived, rapidly diffusible signal in the development and function of the nervous system. Proc. Acad. Natl. Sci. USA, 87: 3547-3551.
12. Garthwaite, J., Charles, S.L. and Chess-Williams, R. (1988) Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in brain. Nature, 336: 385-388.
13. Garthwaite, J. (1991) Glutamine, nitric oxide and cell-cell signaling in the nervous system. Trends Neurosci., 14: 60-67.
14. Gibson, A., Mirzazadeh, S., Hobbs, A.J. and Moore, P.K. (1990) L-NG-Monomethyl arginine and L-NG-nitro arginine inhibit non-adrenergic non-cholinergic relaxation of the mouse anococcygeus. Br. J. Pharmacol., 99: 602-606.
15. Haley, J.E., Sullivan, A.F. and Dickenson, A.H. (1990) Evidence for spinal N-methyl-D-aspartate receptor involvement in prolonged chemical nociception in the rat. Brain Res., 518: 218-226.
16. Heapy, C.G., Jamieson, A., and Russell, N.J.W. (1987) Afferent C-fiber and A-fiber activity in model of inflammation. Br. J. Pharmacol., 90: 164.
17. Hibbs, J.B. Jr, Taintor, R.R. and Vavrin, Z. (1987) Macrophage cytotoxicity: Role for L-arginine deiminase and imino nitrogen oxidation to nitrite. Science, 235: 473-476.
18. Hrabie, J.A., Klose, J.R., Wink, D.A. and Keefer, L.K. (1993) New nitric oxide-releasing Zwitterions derived from polymines. J. Org. Chem., 58: 1472-1476.
19. Ignarro, L.J. (1990) Nitric oxide: A novel signal transduction mechanism for transcellular communication. Hypertension, 16: 477-483.
20. Ji, X.Q. and Zhu, X.Z. (1993) Possible involvement of nitric oxide in arginine-induced analgesia. Act. Pharmacol. Sin., 14: 289.
21. Katayama, Y. (1994) NOC. Dojin News, 69: 21.
22. Kawabata, A., Umeda, N. and Takagi, H. (1993) L-Arginine exerts a dual role in nociceptive processing in the brain: involvement of the kyotorphine-Met-enkephalin pathway and NO-cyclic GMP pathway. Br. J. Pharmacol., 109: 73-79.
23. Kawabata, A., Manabe, S., Manabe, Y. and Takagi, H. (1994) Effect of topical administration of L-arginine on formalin-induced nociception in the mouse: a dual role of peripherally formed NO in pain modulation. Br. J. Pharmacol., 112: 547-550.
24. Katz, J., Kavanagh, B.P., Sandler, A.N., Nierenberg, H., Boylan, J.F., Friedlander, H. and Shaw, B.F. (1992) Preemptive analgesia: Clinical evidence of neuroplasticity contributing to postoperative pain. Anesthesiology, 77: 439-446.
25. Kiss, J. and Mathias, K. (1992) Does opiate premedication influence postoperative analgesia? A prospective study. Pain, 48: 157-158.
26. Kitto, K.F., Haley, J.E. and Wilcox, G.L. (1992) Involvement of nitric oxide in spinally-mediated hyperalgesia in the mouse. Neurosci. Lett., 148: 1-5.
27. Knowles, R.G., Palacios, M., Palmer, R.M.J. and Moncada, S. (1989) Formation of nitric oxide from L-arginine in the central nervous system: a transduction mechanism for stimulation of soluble guanylate cyclase. Proc. Natl. Acad. Sci. USA, 86: 5159-5162.
28. Lincoln, T.M. and Cornwell, T.L. (1993) Intracellular cyclic GMP receptor proteins. FASEB J., 7: 328-338.
29. Malmberg, A.B. and Yaksh, T.L. (1992) Antinociceptive actions of spinal non-steroidal anti-inflammatory agents on the formalin test in the rat. J. Pharmacol. Exp. Ther., 263: 136-146.
30. McCall, T.B., Boughton-Smith, N.K., Palmer, R.M.J., Whittle, B.J.R. and Moncada, S. (1989) Synthesis of nitric oxide from L-arginine by neutrophils. Biochem. J. 261: 293-296.
31. Meller, S.T., Dykstra, C. and Gebhart, G.F. (1992) Production of endogev nous nitric oxide and activation of soluble guanylate cyclase are required for N-methyl-D-aspartate-produced facilitation of the nociceptive tail-flick reflex. Eur. J. Pharmacol., 214: 93-96.
32. Meller, S.T. and Gebhart, G.F. (1993) Nitric oxide (NO) and nociceptive processing in the spinal cord. Pain. 52: 127-136.
33. Moncada, S., Palmer, R.M.J. and Higs, E.A. (1991) Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev., 43:109-142.
34. Moore, P.K., Oluyomi, A.O., Babbedge, R.C., Wallace, P. and Hart, S.L. (1991) L-NG-nitro arginine methyl ester exhibits antinociceptive activity in the mouse. Br. J. Pharmacol., 102: 198-202.
35. O'Dell, T.J., Hawkins, R.D., Kandel, E.R. and Arancio, O. (1991) Test of the roles of two diffusible substances in long-term potentiation: evidence for nitric oxide as a possible early retrograde messenger. Proc. Natl. Acad. Sci. USA, 88: 11285-11289.
36. Palmer, R.M.J., Ferrige, A.G. and Moncada, S. (1987) Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature, 327: 524-526.
37. Palmer, R.M.J., Ashton, D.S. and Moncada, S. (1988) Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature, 333. 664-666.
38. Paxinos, G. and Watson, C., The rat brain in streotaxic coordinates, 2nd ed. Academic Press, New York, NY, 1986.
39. Schuman, E.M. and Madison, D.V. (1991) A requirement for the intercellular messenger nitric oxide in long-term potentiation. Science, 254: 1503-1506.
40. Shibuki, K. and Okada, D. (1991) Endogenous nitric oxide release required for long-term synaptic depression in the cerebellum. Nature, 349: 326-328.
41. Shibuta, S., Mashimo, T., Ohara, A., Zhang, P. and Yoshiya, I. (1995) Intracerebroventricular administration of a nitric oxide-releasing compound, NOC-18 produces thermal hyperalgesia in rats. Neurosci. Lett., 187: 103-106.
42. Shimaoka, M., Iida, T., Ohara, A., Taenaka, N., Mashimo, T., Honda, T. and Yoshiya, I. (1995) NOC, a nitric-oxide-releasing compound, induces dose dependent apoptosis in macrophages. Biochem. Biophys. Res. Commun., 209: 519-526.
43. Snyder, S.H. (1992) Nitric oxide: first in a new class of neurotransmitters? Science, 257: 494-496.
44. Snyder, S.H. and Bredt, D.S. (1991) Nitric oxide as a neural messenger, Trends. Pharmacol. Sci., 12: 125-128.
45. Tseng, L.F., Xu, J. Y. and Pieper, G.M. (1992) Increasing of nitric oxide production by L-arginine potentiates i.c.v. administered β-endorphininduced antinociception in the mouse. Eur. J. Pharmacol., 212: 302-304.
46. Tucker, J.F., Brave, S.R., Charalambous, L., Hobbs, A.J. and Gibson, A. (1990) L-NG-nitro arginine inhibits non-cholinergic relaxation of guinea pig trachea. Br. J. Pharmacol., 100: 663-664.
47. Vocci, F.J., Petty, S.K, and Dewey, W.L. (1978) Antinociceptive action of the butyryl derivatives of cyclic guanosine 3′:5′-monophosphate. J. Pharmacol. Exp. Ther., 207: 892-898.
48. Yuan, S.Y., Bornstein, J.C. and Furness, J.B. (1995) Pharmacological evidence that nitric oxide may be a retrograde messenger in the enteric nervous system. Br. J. Pharmacol., 114: 428-432.